Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort
Acta Oncol
.
2021 Feb;60(2):187-190.
doi: 10.1080/0284186X.2020.1841288.
Epub 2020 Nov 4.
Authors
Irina Tsibulak
1
,
Verena Wieser
1
,
Hannah Welponer
1
,
Katharina Leitner
1
,
Hubert Hackl
2
,
Christian Marth
1
,
Heidelinde Fiegl
1
,
Alain G Zeimet
1
Affiliations
1
Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
2
Institute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
PMID:
33147104
DOI:
10.1080/0284186X.2020.1841288
No abstract available
Publication types
Letter
MeSH terms
BRCA2 Protein* / genetics
Cohort Studies
Female
Humans
Ovarian Neoplasms* / genetics
RNA, Messenger / genetics
Substances
BRCA2 Protein
BRCA2 protein, human
RNA, Messenger